Michael F. Bennet · $500K–$1.0M
Sale · traded 2017-12-08 → filed 2017-12-21. Ranked over every RGC row by the provable lower bound, never a point estimate.
Both disclosure regimes on one name: who in Congress filed about RGC, which institutions reported holding it. Each section keeps its own clock — congressional trades on the 45-day PTR clock, 13F holdings as quarter-end snapshots.
Sale · traded 2017-12-08 → filed 2017-12-21. Ranked over every RGC row by the provable lower bound, never a point estimate.
Counts of disclosures by trade date, not dollars — ranges cannot be netted across members. Flow ranges per member are in the table below.
Late disclosure is stated on the row, never editorialised. Both dates and the receipt stay on every row.
No dated RGC rows fall inside the trailing 24 months by trade date.
Trade date, not filing date — the lag lives in the table below. 0 rows placed.
PLANNED institutional holder flow by quarter
| Filed ▾ | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2018-09-29 | Gary J. Palmer R–AL-6 | Purchase · SP (spouse-owned) | Traded 2017-04-04 LATE·543d | $1K–$15K | ||
| 2018-01-23 | Lois Frankel D–FL-22 | Sale | Traded 01-09 +14d | $1K–$15K | ||
| 2018-01-23 | Lois Frankel D–FL-22 | Sale | Traded 01-08 +15d | $1K–$15K | ||
| 2017-12-21 | Michael F. Bennet D–CO | Sale | Traded 12-08 +13d | $500K–$1M | ||
| 2017-12-20 | Lois Frankel D–FL-22 | Sale | Traded 12-08 +12d | $1K–$15K |
No member disclosed RGC in the trailing 12 months.
filed 2026-06-16 → 2026-09-14 · totals are statutory ranges
Ticker not yet mapped — the 13F side needs a reviewed name-and-class mapping row for RGC. how tickers are mapped ↗
No moves on either side in the window.
RGC resolves to Regencell Bioscience Holdings Ltd (CIK 0001829667), but this build's aggregate holds no entity-keyed top-holder rows for it. RGC on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to Regencell Bioscience Holdings Ltd (CIK 0001829667), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
The ticker resolves to Regencell Bioscience Holdings Ltd (CIK 0001829667), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so the filer side cannot be computed. Convergence and divergence are stated only when both sides are computed.
Zero hits on RGC in the retained window — a computed answer over every rule, not missing coverage.
RGC's as-reported XBRL fundamentals will appear here when the financials module passes its gates. Until then: RGC on EDGAR ↗
Rates, inflation, and positioning series land here with the macro module — vintage-aware, never nowcast.